Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience

被引：2
|
作者：
Adisen, Esra [1 ]
Oztas, Murat Orhan [1 ]
Aksakal, Ahmet Burhan [1 ]
ilter, Nilsel [1 ]
Gulekon, Ayla [1 ]
机构：
[1] Gazi Univ, Fac Med, Dept Dermatol, Ankara, Turkiye
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2023年 / 98卷 / 02期
关键词：
THERAPY;
D O I：
10.1016/j.abd.2022.06.003
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：240 / 242
页数：3
相关论文
共 50 条
  • [41] Omalizumab in chronic spontaneous urticaria treatment: Real life experiences
    Engin, Burhan
    Celik, Ugur
    Birben, Aslihan Ozge
    Askin, Ozge
    Kutlubay, Zekayi
    Serdaroglu, Server
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (04): : 145 - 149
  • [42] Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria
    Syrigos, Nikolaos
    Grapsa, Dimitra
    Zande, Maria
    Tziotou, Marianna
    Syrigou, Ekaterini
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (04) : 417 - 422
  • [43] What are the effects of omalizumab in patients with refractory chronic spontaneous urticaria?
    Lopez, Mario
    Navajas-Galimany, Lucas
    MEDWAVE, 2015, 15 : e6346
  • [44] Comparison of Omalizumab Treatment Response in Patients with Chronic Spontaneous Urticaria and Symptomatic Dermographism: A Single-Center Retrospective Study
    Cakmak, Mehmet Erdem
    Yegit, Osman Ozan
    Oztop, Nida
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (03) : 236 - 242
  • [45] Omalizumab for chronic spontaneous urticaria: a single UK centre experience
    Denman, S.
    Corps, C.
    Ford, K.
    Toolan, J.
    Mistry, A.
    Arumugakani, G.
    Srivastavana, S.
    Wood, P.
    Savic, S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (12): : 1634 - 1635
  • [46] Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab: A Real-Life Experience from a Tertiary Allergy Center
    Ozhan, Aylin Kont
    Arikoglu, Tugba
    CHILDREN-BASEL, 2024, 11 (01):
  • [47] Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experience
    Picone, Vincenzo
    Napolitano, Maddalena
    Martora, Fabrizio
    Guerriero, Luigi
    Fabbrocini, Gabriella
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [48] Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
    Turk, Murat
    Bahcecioglu, Sakine Nazik
    Tutar, Nuri
    Oymak, Fatma Sema
    Gulmez, Inci
    Yilmaz, Insu
    TURKISH THORACIC JOURNAL, 2018, 19 (04) : 187 - 192
  • [49] Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience
    Zhu, Catherine
    BinJadeed, Hessah
    Gabrielli, Sofianne
    Prosty, Connor
    Rahme, Elham
    Shand, Greg
    Fein, Michael
    Ben-Shoshan, Moshe
    Netchiporouk, Elena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1227 - 1231
  • [50] Efficacy and Safety of Omalizumab in Severe Allergic Asthma and Allergic Comorbidities: A Single-Center, Real-Life Experience in China
    Zhao, L.
    Zou, C.
    Zhu, Y.
    Wu, X.
    Wang, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345